• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume9, Issue1

Procalcitonin Use in Sepsis Presentations Among Tertiary Care Patients

    Dr. U.T. Mane, Dr. Desai Jabbar V

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 1, Pages 1764-1777

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

The severity of the illness and the decline in health status of critical patients determine the mortality rate in ICUs. Extremes of age, disease severity, and certain pre-existing comorbidities like diabetes are the factors that contribute to higher hospital death rates (e.g. Malignancy, Immunosuppressed status and patients on renal replacement therapy). Florence Nightingale recognised the need for clinical treatment outcome assessment for the first time in 1863. 2
Initially, the ability and judgement of the doctor was used to predict the outcome in critically ill patients. In order to improve procedures that are mostly based on evidence, the recent rapid rise of intensive care units has necessitated a quantitative evaluation and review of the outcomes. The first disease severity scores and outcome prediction models were created more than 25 years ago with the goal of determining the probability of fatality in critically sick patients. Since then, other Intensive Care unit scoring systems have been created, taking aetiology and varied scenarios into account. As a result, determining the prognosis is an essential component of managing any critically ill cases. 3
Keywords:
  • PDF (468 K)
  • XML
(2022). Procalcitonin Use in Sepsis Presentations Among Tertiary Care Patients. European Journal of Molecular & Clinical Medicine, 9(1), 1764-1777.
Dr. U.T. Mane, Dr. Desai Jabbar V. "Procalcitonin Use in Sepsis Presentations Among Tertiary Care Patients". European Journal of Molecular & Clinical Medicine, 9, 1, 2022, 1764-1777.
(2022). 'Procalcitonin Use in Sepsis Presentations Among Tertiary Care Patients', European Journal of Molecular & Clinical Medicine, 9(1), pp. 1764-1777.
Procalcitonin Use in Sepsis Presentations Among Tertiary Care Patients. European Journal of Molecular & Clinical Medicine, 2022; 9(1): 1764-1777.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 8
  • PDF Download: 5
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus